Schistosoma in Egypt: Prepared By: 407-417 Supervised by
Schistosoma in Egypt: Prepared By: 407-417 Supervised by
Schistosoma in Egypt: Prepared By: 407-417 Supervised by
Egypt
Prepared By:
407-417
Supervised By:
Professor Dr. Suzan Fathy El-Nasery
Dr. Safaa
INTRODUCTION
Schistosomiasis, caused by a trematode helminth, infects over 200
million people,
with eighty percent of infections occurring in sub-Saharan Africa. It was
described in the mid-19th century by Theodor Bilharz; however,
symptoms characteristic
of the disease were described in antiquity and schistosome eggs have
been found in Egyptian and Chinese mummies.
History
A. Schistosomes were first described in Egypt by Theodor Bilharz in 1851,
and Wilhelm Griesinger associated the worms with the disease. They
named the worm Distoma haematobium, but the name didn’t stick.
B. In 1858 the genus Schistosoma was proposed, which did stick, but
there were Johnny-come-lately rivals: Gynaecophorus (1858), Bilhar-zia
(1859), and Thecosoma (1860). Schistosoma had precedence.
G. Early on antimony tartarate was used for therapy and copper sulfate
for killing the intermediate host snails.
C. Usually the infection is acquired in childhood, peaking in the age group of 15–
20 years
S.mekongi
Morphology
Unlike other trematodes, the schistosomes are dioecious - i.e., the sexes
are separate. The two sexes display a strong degree of sexual dimorphism,
and the male is considerably larger than the female. The male surrounds
the female and encloses her within his gynacophoric canal for the entire
adult lives of the worms, where they reproduce sexually.
Morphology
-Adults -Eggs -Miracidium -Sporocyst -Cercaria
-schistosomule
s.hematobium s.mansoni
male female male female
-shape:
Flat elongated
Contain no body cavity
Same but no Same as male Same as female
Folded to form
g.canal hematobium hematobium
gyenchephoric canal to
carry female
Size: 10x1 mm 20x0.25 mm 8x1 mm 14x0.15 mm
Structure:
It is outer covering layer Mora coarsely
Cuticle Smooth Smooth
Tuberculated tuberculated
Testes:
Ovary:
Globular
Single
3-5 n Same as male H
5-genital Post equat.
Behind v.sucker but: Same as femal H but:
system Oviduct
Vasa efferentia Testes 6-9 Ovary pre equat.
Ootype
Vase deference Smaller in size
Uterus
Seminal vesicle
Vitelline gland
cirrus
s.hematobium S,mansoni
oval Oval
140x50 micron 150x65
Faint yellow Yellowish
Non operculated Non operculated
Terminal spine Lateral spine
Contain fully mature Contain fully mature
miracidium miracidium
Embryo (miracidium) :
Piriform
Covered with cilia
Contain:
a) Non primitive gut
b) 1 or 2 pairs of lytic
penetrating glands
c) 1 or 2 pairs of flame cells
d) 2 execretory
tubules
Sporocyst
It is a sac:
• Elongated
• Blind
• Contain germ cells
cercaria:
Consist of :
schistosomule:
• It is derived from cercaria after
penetrating body &leaving its tail
Life Cycle:
Schistosomes have a typical trematode vertebrate-invertebrate lifecycle, with
humans being the definitive host. The life cycles of all five human schistosomes
are broadly similar:
parasite eggs are released into the environment from the stool of infected
individuals, hatching on contact with fresh water to release the free-swimming
miracidium.
Worm pairs migrate to inferior mesenteric veins where S.mansoni settle but s.
hematopium migrate to rectal veins and cross porto systemic shunts through
inferior rectal vein to reach the vesical and pelvic venous plexus where they
settle.
They begin to produce eggs which are laid immature in the very fine capillaries
then acquire maturity in submocosa.
Adult S. mansoni pairs residing in the mesenteric vessels may produce up to 300
eggs per day during their reproductive lives. Many of the eggs pass through the
walls of the blood vessels, and through the intestinal wall, to be passed out of the
body in faeces. S. haematobium eggs pass through the ureteral or bladder wall
and into the urinebut5%of eggs can pass through stool. Up to half the eggs
released by the worm pairs become trapped in the mesenteric veins.
Secreting antigens that elicit a vigorous immune response. The eggs themselves
do not damage the body. Rather it is the cellular infiltration resultant from the
immune response that causes the pathology classically associated with
schistosomiasis.
DAMS Dams and irrigation projects can either increase or decrease the prevalence of
disease.
With the construction of the Aswan Dam in Egypt, S. haematobium in the Nile Delta
decreased but S. mansoni in Upper Egypt increased. Dams built in the 1980s in the Senegal
River Basin caused a great increase in schistosomiasis 2. In contrast, when the Ertan Dam
in China was built, precautions were taken to ensure the prevalence of
schistosomiasis did not increase: concrete irrigation canals and piping systems for the
water supply were installed to eliminate the snails, molluscicides were used, sanitary
facilities were built for the workers, and infected people and cattle were treated with
praziquantel. Currently, the Three Gorges dam project in China is being monitored for
schistosomiasis.
Pathogenesis and pathology:
Schistoso Schistoso Schistoso
Schistoso
Schistosoma ma ma ma
Species ma
mansoni haematobi intercalat japonicu
mekongi
um um m
Bulinus
Biomphalaria glabrata Oncomela
truncatus Tricula
Intermediat B. alexandrina Bulinus nia
Bulinus aperta
e host B. pfeifferi forskali hupensis
globosus a.o.
a.o. a.o.
a.o.
East Asian
Form of the urogenital intestinal intestinal
intestinal bilharziasis intestinal
disease bilharziasis bilharziasis bilharziasis
bilharziasis
Gabun,
East Asia,
Endemic South America, the Carribean, Africa, the Cameroon,
South East Indochina
Areas Africa, the Middle East Middle East Tschad,
Asia
Zaire
katayama Syndrome :
Fever, cough, fatigue, splenomegaly, lymphadenopathy Eosinophilia
(Sometimes PIE…pulmonary infiltrates and eosinophilia)
B) Complications of S. mansoni:
i- Intestinal lesions:
- oedema and pin point haemorrhages due to escape of ova from
blood vessels to the lumen of the intestine.
- Sandy patches due to deposition of large number of calcified ova.
- bilharzial polypi: large mass of bilharzial granulomatous reaction is
formed in submucosa.
- Fissures and perianal sinuses.
ii- Hepatic affection in the form of hepatic fibrosis and this lead
to :
a- portal hypertension - hepatic dysfunction.
b- Splenomegaly- ascites.
N.B. Co-infiction with hepatitis B or C can
accelerate hepatic dysfunction and raise risk for
hepato-celluler carcinoma beyond that seen
with hepatitis alone.
c- Haematemesis: due to portal hypertension that
open portosystemic shunts leading to oesophageal varicose venis
rupture of these veins leading to haemorrhage and vomting of blood.
iii- pulmonary complications:
Ova of S. mansoni carried from the portal circulation to the systemic
circulation and reach the lung. (Due to portal hypertension.)
Diagnosis:
Microscopic identification of eggs in stool or urine is the most practical
method for diagnosis. The stool exam is the more common of the two.
For the measurement of eggs in the feces of presenting patients the
scientific unit used is epg or eggs per gram. Stool examination should be
performed when infection with S. mansoni or S. japonicum is suspected,
and urine examination should be performed if S. haematobium is
suspected.
Eggs can be found in the urine in infections with S. japonicum and with S.
intercalatum (recommended time for collection: between noon and 3
PM). Detection will be enhanced by centrifugation and examination of the
sediment. Quantification is possible by using filtration through a
nucleopore membrane of a standard volume of urine followed by egg
counts on the membrane. Investigation of S. haematobium should also
include a pelvic x-ray as bladder wall calcificaition is highly characteristic
of chronic infection.
Procedures
Rectal biopsy or bladder mucosal biopsy
o Mucosal biopsy is effective for visualizing eggs.
o Biopsy is helpful when stool sample findings are negative or
in light infection.
o Obtain multiple biopsy samples and crush them between
slides (to increase egg-detecting sensitivity).
• Sigmoidoscopy/proctoscopy
o To obtain mucosal biopsies (including rectal)
o For diagnosis and to identify complications such as
pedunculated and sessile polyps
• Upper endoscopy
o Assess for esophageal varices.
o Treat upper intestinal bleeding with endoscopic
sclerotherapy.
• Cystoscopy
o To obtain mucosal biopsy for diagnosis
o To assess complications such as bladder cancer
• Surgical biopsy findings may be used to diagnose ectopic
schistosomiasis.
Treatment
Antimony has been used in the past to treat the disease. In low doses, this
toxic metalloid bonds to sulfur atoms in enzymes used by the parasite and
kills it without harming the host. This treatment is not referred to in
present-day peer-review scholarship.
:Adult Dose -
S haematobium and S mansoni: 40 mg/kg/d PO divided bid for 1 d
S japonicum and S mekongi: 60 mg/kg/d PO divided tid for 1 d
:Pediatric Dose -
S haematobium and S mansoni: 40 mg/kg/d PO divided bid for 1 d
S japonicum and S mekongi: 60 mg/kg/d PO divided tid for 1 d
:Contraindications -
Documented hypersensitivity; ocular cysticercosis
:Interactions -
Hydantoins may reduce serum praziquantel concentrations, possibly
leading to treatment failures
:Pregnancy -
B - Fetal risk not confirmed in studies in humans but has been
shown in some studies in animals
:Precautions -
Destruction of parasite within the eyes can cause irreparable lesions
(ocular cysticercosis should not be treated with praziquantel);
caution while driving or performing other tasks requiring alertness
on the day of and following treatment; minimal increases in liver
enzyme levels reported; when schistosomiasis or fluke infection is
associated with cerebral cysticercosis, hospitalize patient for
duration of treatment
:Adult Dose -
mg/kg PO as single dose 15
:Pediatric Dose -
mg/kg PO divided bid for 1 d 20
:Contraindications -
Documented hypersensitivity
:Interactions -
None reported; food may delay absorption
:Pregnancy -
D - Fetal risk shown in humans; use only if benefits outweigh risk to
fetus
:Precautions -
Use caution and closely monitor in patients with history of seizures
because they may experience epileptiform convulsions; EEG
abnormalities may develop in patients with normal pretreatment
recordings
:Contraindications -
The drug is contraindicated in patients with prior hypersensitivity to
.artesunate or artemisinin derivatives
Oral artesunate should not be used during the first trimester of
.pregnancy
- Interactions:
Artesunate has a minimal effect on hepatic cytochrome P450
activity and does not appear to influence the metabolism of
mefloquine, a drug likely to be used in combination with artesunate.
Artersunate does not inhibit the formation of carboxy-primaquine, a
metabolite of primaquine.
- Pregnancy:
Little experience has been gained with the use of artesunate in
pregnancy, but the parenteral preparation should not be withheld if
it is considered life-saving to the mother. Oral artesunate should not
be used during the first trimester of pregnancy.
:Precautions -
Parenteral artesunate should be used for the treatment of severe
falciparum malaria only where there is evidence that the
.antimalarial efficacy of quinine is declining
Prevention
A. Treatment of cases to reduce egg loads may be the cheapest
.solution
B. Reduction or elimination of snail intermediate hosts
C. Elimination of snail habitats
D. Sanitation measures
E. Protective footwear
!F. Don’t swim in the Nile
• ADULT adult males are approximately 1 cm long and 0.11 cm wide; adult
females are approximately 1.4 cm long and 0.016 cm wide; the adults can live for
years; male and female are always hugged together; up to half the eggs released
by the worm pairs become trapped in the mesenteric veins, or will be washed back
into the liver, where they will become lodged; trapped eggs mature normally,
secreting antigens that elicit a vigorous immune response
References
- Principles and Practice of Clinical Parasitology Edited By
S.Gillespie & Richard D. Pearson, Copyright © 2001 John Wiley &
Sons Ltd
- J Dick MacLean, McGill Centre for Tropical Diseases, Montreal
- NovaTec, Immunodiagnostica GMBH v 04.2007
- CMPT Connections “on-line” Volume 11 Number 3—Fall 2007
- Bulletin of the World Health Organization 2003, 81 (3)
http://www.bioportfolio.com/indepth/Schistosomiasis_Haematobia.ht
ml
http://en.wikipedia.org/wiki/Schistosoma_haematobium
http://en.wikipedia.org/wiki/Schistosoma_mansoni
http://www.emedicine.com/radio/topic621.htm
http://en.wikipedia.org/wiki/Schistosomiasis
http://www.cartercenter.org/health/schistosomiasis/treatment.html
Supervised
By:
Professor Dr. Suzan Fathy El-